About | Free Trial

Last Update

2016-05-08T00:00:00.000Z

This profile was last updated on // .

Is this you? Claim your profile.

Wrong Herbert Nagasawa?

Dr. Herbert Nagasawa T.

Executive Research Scientist

Max International LLC

HQ Phone: (801) 316-6380

Max International LLC

6965 South Union Park Center Suite 100

Salt Lake City, Utah 84047

United States

Company Description

Max International was founded by dedicated and successful entrepreneurs and executives who had a vision. After meeting with Dr. Keller and learning about MaxGXL they knew this was a product that everyone needs. They also know the best way to help people ... more

Find other employees at this company (418)

Background Information

Employment History

Principal Scientist
VA Medical Center

Visiting Professor
Washington State University

Ad Hoc Grant Reviewer
NIAAA

Affiliations

Post-doctoral Fellow In Biochemistry
University of Minnesota

Education



National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium

B.S. degree
chemistry
Western Reserve University

Ph.D.

Ph.D. degree
organic chemistry
University of Minnesota

Ph.D.'s RiboCeine invention

Web References (200 Total References)


RiboCeine was developed by the ...

max4u.com [cached]

RiboCeine was developed by the world-renowned research scientist and medicinal chemist, Herbert T. Nagasawa, Ph.D. Dr. Nagasawa was a Professor of Medicinal Chemistry and Toxicology at the University of Minnesota for forty years and at the same time he was named Senior Career Research Scientist for the Veterans Administration in Minneapolis. For thirty-two of those years he was Senior Editor of the Journal of Medicinal Chemistry. Dr. Nagasawa now serves as the Executive Scientist for Max International.


Although Max was founded only ...

max4u.com [cached]

Although Max was founded only in 2007, our growing expertise is based on more than 25 years of research performed by Dr. Herbert Nagasawa, who joined Max in 2009.

...
Dr. Herbert T. Nagasawa, Executive Research Scientist Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals. In June of 2010, Herb attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium held in San Francisco. Herb and the team of scientists presented their work on the cyanide antidote.
...
Scott, an original co-founder of CellGevity, then left to join Dr. Herb Nagasawa and Scott Momii at CellGevity, and served full-time as the Chief Technical Officer (CTO).


The creator of RiboCeineā„¢ - ...

max4u.com [cached]

The creator of RiboCeineā„¢ - Herbert T. Nagasawa, Ph.D., Executive Research Scientist

Chief Scientist and co-founder of CellGevity, Inc., Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and the Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973. He also held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health. He has published over 165 papers in peer-reviewed journals, and is the inventor named on ten U.S. and PCT patent applications.


Glutathione | Boston Hormone Replacement Therapy

www.bostontestosterone.com [cached]

Read also the following excerpt from Dr. Herbert Nagasawa, one of the worlds leading research scientists on cellular function.

...
Dr. Nagasawa received his B.S. degree in chemistry from Western Reserve University (now, Case-Western Reserve) in Cleveland, Ohio, and a Ph.D. degree in organic chemistry from the University of Minnesota. Subsequently, he spent two years as a Post-doctoral Fellow in biochemistry at the University of Minnesota before joining the research staff of the V.A. Medical Center in Minneapolis as a Senior Chemist. He was appointed Assistant Professor of Medicinal Chemistry at the University of Minnesota in 1959. He was named Principal Scientist of the VAMC in 1961 and was promoted in 1976 to Senior Research Career Scientist, a nationwide VA title reserved for the VA's top scientists. He was promoted to Associate Professor in 1963 and to Professor of Medicinal Chemistry in 1973.
Dr. Nagasawa has held joint professorships in the Department of Pharmacology and the university-wide Division of Toxicology, and served as Visiting Professor at Washington State University in 1990. He also served for 32 years as a Senior Editor for the prestigious international Journal of Medicinal Chemistry from 1972 to 2004, and one year as Acting Editor-in-Chief. In addition, he served on the Editorial Board of the journal, Bioconjugate Chemistry for eight years, and as an ad hoc grant reviewer for the NCI and NIAAA, National Institutes of Health.
Dr. Nagasawa has published over 165 papers in peer-reviewed journals. In June of 2010, Dr. Nagasawa and his team attended the National Institutes of Health-Homeland Security 4th Annual Countermeasures Against Chemical Threats Network Symposium to present their work on the cyanide antidote.
Dr. Nagasawa ha long been regarded as one of the worlds leading research scientists on cellular function, Glutathione and the chemistry and delivery of Glutathione. He and his laboratory have be awarded an extraordinary 9 patents.


Max International

maxgxl.com [cached]

RiboCeine was developed by the world-renowned research scientist and medicinal chemist, Herbert T. Nagasawa, Ph.D. Dr. Nagasawa was a Professor of Medicinal Chemistry and Toxicology at the University of Minnesota for forty years and at the same time he was named Senior Career Research Scientist for the Veterans Administration in Minneapolis. For thirty-two of those years he was Senior Editor of the Journal of Medicinal Chemistry. Dr. Nagasawa now serves as the Executive Scientist for Max International.

Similar Profiles

Other People with this Name

Other people with the name Nagasawa

Shohei Nagasawa
TPG N.V.

Hiroshi Nagasawa
NEC Corporation

Yuji Nagasawa
Ernst & Young LLP

Hironobu Nagasawa
Pruftechnik Ltd

Scott Nagasawa
Max International LLC

Browse ZoomInfo's Business Contact Directory by City

Browse ZoomInfo's
Business People Directory

Browse ZoomInfo's
Advanced Company Directory